Oct 28, 2024 04:44PM
Nov 9, 2020 08:05AM
Jan 6, 2020 07:33AM
Jan 6, 2020 07:30AM
Dec 16, 2019 06:58PM
Dec 2, 2019 08:33AM
Dec 2, 2019 08:30AM Oragenics, Inc. Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral Mucositis
Nov 5, 2019 04:01PM
Oct 22, 2019 08:00AM
Sep 30, 2019 08:03AM
Sep 30, 2019 08:00AM
Sep 25, 2019 08:03AM
Sep 25, 2019 08:00AM
Aug 19, 2019 07:31AM Intrexon (XON) Subsidiary ActoBio Therapeutics Grantef IND Green Light for New Antigen-Specific Immunotherapy Study
Aug 19, 2019 07:30AM
Aug 14, 2019 04:45PM
Aug 6, 2019 04:05PM
May 29, 2019 08:08AM
May 29, 2019 08:00AM
May 29, 2019 08:00AM
May 20, 2019 07:48AM Oragenics (OGEN) Announces Development Update of AG013 for Oral Mucositis
May 20, 2019 07:45AM
May 16, 2019 09:27AM
May 15, 2019 07:30AM
May 9, 2019 04:10PM
May 2, 2019 04:30PM
May 2, 2019 04:30PM
Apr 15, 2019 06:32AM Fibrocell Science (FCSC) Announces Pact with Castle Creek Pharma to Develop and Commercialize FCX-007 Gene Therapy
Apr 15, 2019 06:30AM
Apr 15, 2019 06:30AM
Apr 2, 2019 07:00AM
Apr 2, 2019 07:00AM
Mar 27, 2019 07:32AM
Mar 27, 2019 07:30AM
Mar 20, 2019 08:00AM Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
Mar 8, 2019 03:21PM
Mar 8, 2019 03:19PM
Mar 8, 2019 03:19PM
Mar 7, 2019 05:00PM
Mar 7, 2019 05:00PM
Feb 28, 2019 04:15PM
Feb 11, 2019 07:36AM Intrexon (XON) Subsidiary Precigen Announces Clearance of IND to Initiate Phase 1 Study for First-in-Class PRGN-3005 UltraCAR-T
Feb 11, 2019 07:30AM
Feb 6, 2019 08:00AM
Dec 24, 2018 07:30AM
Dec 21, 2018 12:35PM
Dec 21, 2018 07:31AM
Dec 21, 2018 07:30AM
Dec 11, 2018 08:00AM Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Nov 28, 2018 07:37AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All